|1.||Keiser, Jennifer: 2 articles (09/2013 - 06/2012)|
|2.||Ellis, William: 2 articles (09/2013 - 06/2012)|
|3.||Ingram, Katrin: 2 articles (09/2013 - 06/2012)|
|4.||Duthaler, Urs: 1 article (09/2013)|
|5.||Vargas, Mireille: 1 article (09/2013)|
09/01/1984 - "Evaluation of the 4-pyridinemethanol WR 180,409 (enpiroline) in the treatment of induced Plasmodium falciparum infections in healthy, non-immune subjects."
09/01/2013 - "mansoni infections in mice influence the PK profiles of enpiroline and mefloquine, leading to delayed clearance. "
09/01/2013 - "mansoni infection on the pharmacokinetic (PK) parameters of two promising antischistosomal lead candidates (mefloquine and enpiroline) in mice. "
01/01/1989 - "falciparum, but still requiring further investigations on resistance and cross-resistance, as well as its pharmacokinetics, tolerability and bioavailability; d) enpiroline, another promising compound, which needs to be further studied in Phase II and Phase III investigations with naturally acquired malaria. "
|4.||Body Weight (Weight, Body)